1. Home
  2. CMRX vs MEC Comparison

CMRX vs MEC Comparison

Compare CMRX & MEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMRX
  • MEC
  • Stock Information
  • Founded
  • CMRX 2000
  • MEC 1945
  • Country
  • CMRX United States
  • MEC United States
  • Employees
  • CMRX N/A
  • MEC N/A
  • Industry
  • CMRX Biotechnology: Pharmaceutical Preparations
  • MEC Industrial Specialties
  • Sector
  • CMRX Health Care
  • MEC Industrials
  • Exchange
  • CMRX Nasdaq
  • MEC Nasdaq
  • Market Cap
  • CMRX 394.1M
  • MEC 324.5M
  • IPO Year
  • CMRX 2013
  • MEC 2019
  • Fundamental
  • Price
  • CMRX $8.51
  • MEC $13.40
  • Analyst Decision
  • CMRX Hold
  • MEC Strong Buy
  • Analyst Count
  • CMRX 4
  • MEC 3
  • Target Price
  • CMRX $8.51
  • MEC $20.67
  • AVG Volume (30 Days)
  • CMRX 8.5M
  • MEC 135.5K
  • Earning Date
  • CMRX 03-21-2025
  • MEC 03-04-2025
  • Dividend Yield
  • CMRX N/A
  • MEC N/A
  • EPS Growth
  • CMRX N/A
  • MEC 226.32
  • EPS
  • CMRX N/A
  • MEC 1.24
  • Revenue
  • CMRX $212,000.00
  • MEC $581,604,000.00
  • Revenue This Year
  • CMRX $2,685.38
  • MEC $4.91
  • Revenue Next Year
  • CMRX $1,050.23
  • MEC $1.59
  • P/E Ratio
  • CMRX N/A
  • MEC $10.83
  • Revenue Growth
  • CMRX N/A
  • MEC N/A
  • 52 Week Low
  • CMRX $0.75
  • MEC $12.75
  • 52 Week High
  • CMRX $8.53
  • MEC $23.02
  • Technical
  • Relative Strength Index (RSI)
  • CMRX 83.55
  • MEC 33.32
  • Support Level
  • CMRX $8.41
  • MEC $13.73
  • Resistance Level
  • CMRX $8.52
  • MEC $14.07
  • Average True Range (ATR)
  • CMRX 0.02
  • MEC 0.43
  • MACD
  • CMRX -0.14
  • MEC -0.03
  • Stochastic Oscillator
  • CMRX 72.22
  • MEC 17.43

About CMRX Chimerix Inc.

Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.

About MEC Mayville Engineering Company Inc.

Mayville Engineering Co Inc is involved in a manufacturing partner that provides a broad range of prototyping and tooling, production fabrication, coating, assembly, and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, power sports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly and logistic services.

Share on Social Networks: